Experience of Pediatric Radiation Oncology Peer Review Meetings: First Step Toward Centralizing Pediatric

Bilal Mazhar Qureshi1, Maheen Zakaria1, Maria Tariq1

  • 1Radiation Oncology Section, Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan.

PubMed

Insights

Virtual Pediatric Radiation Oncology Peer Review Meetings (PROPRMs) improved pediatric cancer care in Pakistan by standardizing treatment and enhancing quality assurance. This collaborative approach addresses disparities in low-resource settings.

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Healthcare Disparities

Background:

  • Significant disparities exist in pediatric cancer outcomes between high and low Sociodemographic Index (SDI) regions.
  • Limited pediatric radiation oncology expertise in regions like Pakistan necessitates robust quality assurance (QA).
  • Virtual Pediatric Radiation Oncology Peer Review Meetings (PROPRMs) were established to centralize expertise and standardize care.

Purpose of the Study:

  • To evaluate the feasibility and effectiveness of virtual PROPRMs in Pakistan.
  • To improve quality assurance and standardize treatment for pediatric cancer patients.
  • To identify systemic gaps and educational needs in pediatric radiation oncology.

Main Methods:

  • Analysis of data from virtual PROPRM sessions held between June 2022 and March 2025.
  • Multidisciplinary meetings involving pediatric oncologists and radiation oncologists from various centers.
  • Documentation and statistical analysis of case volume, diagnoses, and management adjustments.

Main Results:

  • 130 cases were reviewed across 46 sessions, with soft-tissue sarcomas and bone tumors being the most common diagnoses.
  • Management changes, particularly in radiation therapy (RT) planning (dose, technique, OAR constraints), were recommended in 70.8% of cases.
  • Recurring educational gaps and needs for improved multidisciplinary coordination were identified.

Conclusions:

  • The virtual PROPRM model is a feasible and effective strategy for improving QA in resource-limited settings.
  • This framework centralizes specialized expertise, leading to standardized care and potentially reducing global childhood cancer outcome disparities.
  • The program identified systemic gaps, offering a sustainable approach to enhance pediatric cancer treatment quality.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
609
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K